HUTCHMED (China) (HMDCF) FCF Margin (2018 - 2021)
HUTCHMED (China)'s (HMDCF) quarterly FCF Margin came in at 127.34% in Q2 2021, up 6918.0% year-over-year from 1.81% in Q2 2020, and up 737.18% quarter-over-quarter from 19.99% in Q1 2021.
Powered by 
Analysis
HUTCHMED (China) (HMDCF) FCF Margin (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported FCF Margin for 4 consecutive years, with 127.34% the latest figure, recorded in Q2 2021.
- On a quarterly basis, FCF Margin rose 6918.0% year-over-year to 127.34% in Q2 2021; TTM through Jun 2021 was 42.66%, a 63.0% increase from a year earlier, with the FY2025 full-year figure at 9.21%, down 1213.0% from the prior year.
- FCF Margin was 127.34% for Q2 2021 at HUTCHMED (China), up from 19.99% in the prior quarter.
- Over five years, FCF Margin peaked at 127.34% in Q2 2021 and troughed at 23.03% in Q2 2018.
- A 4-year average of 32.5% and a median of 22.96% in 2018 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin tumbled 5741 bps in 2020 and jumped 6918 bps in 2021, its largest moves.
- Over 4 years, FCF Margin stood at 7.79% in 2018, then surged by 389 bps to 38.12% in 2019, then soared by 53 bps to 58.16% in 2020, then soared by 119 bps to 127.34% in 2021.
- The last three FCF Margin figures came in at 127.34% (Q2 2021), 19.99% (Q1 2021), and 58.16% (Q2 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.50 Bn | 197.51 Bn | 7.24 Bn | 34.70% |
| 2 | Gilead Sciences | 181.29 Bn | 178.11 Bn | 6.22 Bn | 44.00% |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 30.39% |
| 4 | Regeneron Pharmaceuticals | 82.55 Bn | 74.56 Bn | 3.93 Bn | 13.35% |
| 5 | Argenx Se | 61.65 Bn | 56.47 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.65 Bn | 49.52 Bn | 52.00 Mn | -388.28% |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn | 22.62% |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn | 14.91% |
| 9 | Roivant Sciences | 30.01 Bn | 30.01 Bn | 1.16 Mn | -18,629.40% |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 127.34% |
| Mar 31, 2021 | -19.99% |
| Jun 30, 2020 | 58.16% |
| Mar 31, 2020 | 0.64% |
| Dec 31, 2019 | 38.12% |
| Sep 30, 2019 | 71.42% |
| Jun 30, 2019 | 7.21% |
| Mar 31, 2019 | 58.05% |
| Dec 31, 2018 | 7.79% |
| Sep 30, 2018 | 2.84% |
| Jun 30, 2018 | -23.03% |
| Mar 31, 2018 | 61.44% |